arrow
B

Bas Peters

Erasmus MC
H指数:20
被引数:3,523

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer

糖皮质激素和二线免疫抑制剂对非小细胞肺癌免疫相关不良事件后检查点抑制剂的有效性

2026-01-200
OAAI
Real world effectiveness of durvalumab in stage III unresectable non-small cell lung cancer: what is the role of PD-L1 expression?

III期不可切除非小细胞肺癌 durvalumab 的真实世界有效性:PD-L1 表达的作用是什么?

2025-07-170
OAAI
The Toxicity Profile of Pemetrexed in Non-Small Cell Lung Cancer Patients With Moderate Renal Impairment: A Retrospective Cohort Study

培美曲塞在中度肾功能不全的非小细胞肺癌患者中的毒性特征:一项回顾性队列研究

2025-03-260
OAAI
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment
2024-05-270
PRE
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort

在前瞻性多中心队列中使用绝对和相对牛皮癣面积和严重程度指数评分直接比较生物制剂对牛皮癣的实际有效性

2022-05-1611
OAAI